about
Biomarkers of alcohol misuse: recent advances and future prospectsPolymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung CancerHyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo StudiesDynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings.Betulin and betulinic acid attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production and by influencing intracellular signaling.Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling.Zinc inhibits ethanol-induced HepG2 cell apoptosis.Influence of Ivabradine on the Anticonvulsant Action of Four Classical Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice.Peripheral blood dendritic cells in alcoholic and autoimmune liver disorders.Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.Bcl-2 and Fas expression in peripheral blood leukocytes of patients with alcoholic and autoimmune liver disorders.Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease
P50
Q26746815-DCC79B45-F769-40DB-9055-2CF23FD405ECQ33844457-A82B8BDB-B053-4773-9AE7-818121C127A3Q35858593-5B8244B4-2E38-4E08-8EB0-C759630B0AF5Q35941446-D2E3E750-FDAE-4794-A623-0174DCDFEE5BQ36334425-E911A569-7FF9-440D-9D40-CA3CC49A8285Q37412625-D2BF512F-F2C4-47E8-9D45-1000F410CCD3Q39617873-2BA7D469-27C6-4B3C-A222-2161AC9D9B76Q39859469-276B54FC-1616-441D-8014-777361C27AFBQ39994078-81E34A2D-9B18-4335-9319-DA845B6FBC8BQ42293130-B0C1124F-EBFC-4DA9-81B1-15EC60E9CEC0Q43733258-535FDA72-F73A-4D84-BD88-F7A8359F66A8Q44397452-E200F973-89F3-4571-9532-45E29A239B14Q53324218-941F6F1C-CF21-4AF6-877B-175765FC0900Q55040850-5904611B-6A24-4A1C-8666-D76F2DCEBF19Q95549478-C3280F5A-36B9-4056-85D5-1DB4F07CA056
P50
description
Pools onderzoekster
@nl
researcher ORCID ID = 0000-0002-0635-2221
@en
name
Jadwiga Daniluk
@ast
Jadwiga Daniluk
@ca
Jadwiga Daniluk
@cs
Jadwiga Daniluk
@en
Jadwiga Daniluk
@es
Jadwiga Daniluk
@gl
Jadwiga Daniluk
@hr
Jadwiga Daniluk
@hsb
Jadwiga Daniluk
@it
Jadwiga Daniluk
@nl
type
label
Jadwiga Daniluk
@ast
Jadwiga Daniluk
@ca
Jadwiga Daniluk
@cs
Jadwiga Daniluk
@en
Jadwiga Daniluk
@es
Jadwiga Daniluk
@gl
Jadwiga Daniluk
@hr
Jadwiga Daniluk
@hsb
Jadwiga Daniluk
@it
Jadwiga Daniluk
@nl
prefLabel
Jadwiga Daniluk
@ast
Jadwiga Daniluk
@ca
Jadwiga Daniluk
@cs
Jadwiga Daniluk
@en
Jadwiga Daniluk
@es
Jadwiga Daniluk
@gl
Jadwiga Daniluk
@hr
Jadwiga Daniluk
@hsb
Jadwiga Daniluk
@it
Jadwiga Daniluk
@nl
P106
P1153
7005646757
P1412
P1559
Jadwiga Daniluk
@pl
P21
P27
P31
P3124
P496
0000-0002-0635-2221